Diagnostic performance of one-step nucleic acid amplification for intraoperative sentinel node metastasis detection in breast cancer patients

International Journal of Cancer

Volumn 130, Issue 10, 2012, Pages 2377-2386

  Le Frère Belda, Marie Aude ^a   Bats, Anne Sophie ^a   Gillaizeau, Florence ^a   Poulet, Bruno ^b   Clough, Krishna B ^c   Nos, Claude ^a,c   Peoc'H, Michel ^d   Seffert, Pierre ^d   Bouteille, Catherine ^d   Leroux, Agnès ^e   Guillemin, François ^e   Blanc Fournier, Cécile ^f   Crouet, Hubert ^f   Arnould, Laurent ^g   Cuisenier, Jean ^g   Penault Llorca, Frédérique ^h   Gimbergues, Pierre ^h   Jacquemier, Jocelyne ⁱ   Houvenaeghel, Gilles ⁱ   Chatellier, Gilles ^a   Lécuru, Fabrice ^a   more..

^a HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^b Institut de Pathologie   (France)

^c Paris Breast Center   (France)

^d UNIVERSITÉ JEAN MONNET   (France)

^e CENTRE ALEXIS VAUTRIN   (France)

^f CENTRE FRANÇOIS BACLESSE   (France)

^g UNIVERSITÉ DE BOURGOGNE   (France)

^h UNIVERSITÉ CLERMONT AUVERGNE   (France)

ⁱ AIX MARSEILLE UNIVERSITY   (France)

Author keywords

breast cancer; cytokeratin 19; intraoperative molecular analysis; sentinel lymph node metastasis

Indexed keywords

CYTOKERATIN 19; ESTROGEN RECEPTOR; MESSENGER RNA; PROGESTERONE RECEPTOR;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER GRADING; CANCER INVASION; CANCER STAGING; CLINICAL CLASSIFICATION; DIAGNOSTIC TEST ACCURACY STUDY; FALSE POSITIVE RESULT; FROZEN SECTION; GENE DOSAGE; GOLD STANDARD; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTRADUCTAL CARCINOMA; INTRAOPERATIVE PERIOD; INVASIVE CARCINOMA; LYMPH NODE METASTASIS; MACROMETASTASIS; MAJOR CLINICAL STUDY; METASTASIS; MICROMETASTASIS; MOLECULAR IMPRINTING; MULTICENTER STUDY; NUCLEIC ACID AMPLIFICATION; ONCOGENE NEU; ONE STEP NUCLEIC ACID AMPLIFICATION; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE; ST GALLEN RISK CATEGORY; TISSUE SECTION; TOUCH IMPRINT CYTOLOGY;

ADULT; AGED; AGED, 80 AND OVER; AXILLA; BREAST NEOPLASMS; FEMALE; HUMANS; INTRAOPERATIVE PERIOD; KERATIN-19; LYMPHATIC METASTASIS; MIDDLE AGED; NUCLEIC ACID AMPLIFICATION TECHNIQUES; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY;

EID: 84859106885     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.26291     Document Type: Article

References (37)

1. Krag DN, Anderson SJ, Julian TB, Brown AM, Harlow SP, Costantino JP, Ashikaga T, Weaver DL, Mamounas EP, Jalovec LM, Frazier TG, Noyes RD, et al. Sentinel-lymph node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol 2010; 11: 927-33.
2. Cote RJ, Peterson HF, Chaiwun B, Gelber RD, Goldhirsch A, Castiglione-gertsch M, Gusterson B, Neville AM,. Role of immunohistochemical detection of lymph-node metastasis in management of breast cancer. Lancet 1999; 354: 896-900. (Pubitemid 29424019)
3. Cserni G, Amendoeira I, Apostolikas N, Bellocq JP, Bianchi S, Boecker W, Borisch B, Connolly CE, Decker T, Dervan P, Drijkoningen M, Ellis IO, et al. Discrepancies in current practice of pathological evaluation of sentinel lymph nodes in breast cancer. Results of a questionnaire-based survey by the European Working Group for Breast Screening Pathology. J Clin Pathol 2004; 57: 695-701. (Pubitemid 38901482)
4. Cserni G, Amendoeira I, Apostolikas N, Bellocq JP, Bianchi S, Bussolati G, Boecker W, Borish B, Connolly CE, Decker T, Dervan P, Drijkoningen M, et al. Pathological work-up of sentinel lymph nodes in breast cancer. Review of current data to be considered for the formulation of guidelines. Eur J Cancer 2003; 39: 1654-67. (Pubitemid 36897601)
5. Gillanders WE, Mikhitarian K, Hebert R, Mauldin PD, Palesch Y, Walters C, Urist MM, Mann GB, Doherty G, Herrmann VM, Hill AD, Eremin O, et al. Molecular detection of micrometastatic breast cancer in histopathology-negative axillary lymph nodes correlates with traditional predictors of prognosis. An interim analysis of a prospective multi-institutional cohort study. Ann Surg 2004; 239: 828-40. (Pubitemid 38669433)
6. Hughes SJ, Xi L, Raja S, Gooding W, Cole DJ, Gillanders WE, Mikhitarian K, McCarty K, Silver S, Ching J, McMillan W, Luketich JD, et al. A rapid fully automated, molecular-based assay accurately analyzes sentinel lymph nodes for the presence of metastatic breast cancer. Ann Surg Oncol 2006; 234: 389-98. (Pubitemid 43327772)
7. Weigelt B, Verduijn P, Bosma AJ, Rutgers EJ, Peterse HL, van't Veer LJ,. Detection of metastasis in sentinel lymph nodes of breast cancer patients by multiple mRNA markers. Br J Cancer 2004; 90: 1531-7. (Pubitemid 38648234)
8. Sakaguchi M, Virmani A, Dudak MW, Peters GN, Leitch AM, Saboorian H, Gazdar AF, Euhus DM,. Clinical relevance of reverse transcriptase-polymerase chain reaction for the detection of axillary lymph node metastasis in breast cancer. Ann Surg Oncol 2003; 10: 117-25. (Pubitemid 40485930)
9. Nissan A, Jager D, Roystacher M, Prus D, Peretz T, Eisenberg I, Freund HR, Scanlan M, Ritter G, Old LJ, Mitrani-Rosenbaum S,. Multimarker RT-PCR assay for the detection of minimal residual disease in sentinel lymph nodes of breast cancer patients. Br J Cancer 2006; 94: 681-5. (Pubitemid 43361899)
10. Julian TB, Blumencranz P, Deck K, Whitworth P, Berry DA, Berry SM, Rosenberg A, Chapgar AB, Reintgen D, Beitsch P, Simmons R, Saha S, et al. Novel intraoperative molecular test for sentinel lymph node metastasis in patients with early-stage breast cancer. J Clin Oncol 2008; 26: 3338-45.
11. Viale G, Dell'Orto P, Biasi MO, Stufano V, De Brito Lima LN, Paganelli G, Maisonneuve P, Vargo JM, Green G, Cao W, Swijter A, Mazzarol G,. Comparative evaluation of an extensive histopathologic examination and a real-time reverse-transcription-polymerase chain reaction assay for mammaglobin and cytokeratin 19 on axillary sentinel lymph nodes of breast carcinoma patients. Ann Surg 2008; 247: 136-42.
12. Tsujimoto M, Nakabayashi K, Yoshidome K, Kaneko T, Iwase T, Akiyama F, Kato Y, Tsuda H, Ueda S, Sato K, Tamaki Y, Noguchi S, et al. One-step nucleic acid amplification for intra-operative detection of lymph node metastasis in breast cancer patients. Clin Cancer Res 2007; 13: 4807-16. (Pubitemid 47294788)
13. Schem C, Maass N, Bauerschlag DO, Carstensen MH, Löning T, Roder C, Batic O, Jonat W, Tiemann K,. One-step nucleic acid amplification-a molecular method for the detection of lymph node metastasis in breast cancer patients; results of the German study group. Virchows Arch 2009; 454: 203-10.
14. Tamaki Y, Akiyama F, Iwase T, Kaneko T, Tsuda H, Sato K, Ueda S, Mano M, Masuda N, Takeda M, Tsujimoto M, Yoshidome K, et al. Molecular detection of lymph node metastasis in breast cancer patients: results of a multicenter trial using the one-step nucleic acid amplification assay. Clin Cancer Res 2009; 15: 2879-84.
15. Visser M, Jiwa M, Horstman A, Brink AATP, Pol RP, van Diest P, Snijders PJF, Meijer CJLM,. Intra-operative rapid diagnostic method based on CK19 mRNA expression for the detection of lymph node metastasis in breast cancer. Int J Cancer 2008; 122: 2562-7. (Pubitemid 351590490)
16. Snook KL, Layer GT, Jackson PA, de Vries CS, Shousha S, Sinnett HD, Nigar E, Singhal H, Chia Y, Cunnick G, Kissin MW,; for the OSNA Study Group. Multicentre evaluation of intraoperative molecular analysis of sentinel lymph nodes in breast carcinoma. Br J Surg 2011; 98: 527-35.
17. Feldman S, Krishnamurthy S, Gillanders W, Gittleman M, Beitsch PD, Young PR, Streck CJ, Whitworth PW, Levine EA, Boolbol S, Han LK, Hermann R, et al. A novel automated assay for the rapid identification of metastatic breast carcinoma in sentinel lymph nodes. Cancer 2011; 117: 2599-607.
18. Singletary SE, Allred C, Ashley P, Bassett LW, Berry D, Bland KI, Borgen PI, Clark GM, Edge SB, Hayes DF, Hughes LL, Hutter RV, et al. Revision of the American Joint Committee on Cancer staging system breast cancer. J Clin Oncol 2002; 20: 3628-36. (Pubitemid 34983222)
19. Singletary SE, Greene FL,. Breast Task Force. Revision of breast cancer staging: the 6th edition of the TMN classification. Semin Surg Oncol 2003; 21: 53-9. (Pubitemid 37127474)
20. Goldhirsch A, Wood WC, Gelber RD, Coates AS, Thürlimann B, Senn HJ,. Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007. Ann Oncol 2007; 18: 1133-44. (Pubitemid 47244357)
21. Notomi T, Okayama H, Masabuchi H, Yonekawa T, Watanabe K, Amino N, Hase T,. Loop-mediated isothermal amplification of DNA. Nucleic Acids Res 2000; 28: E63.
22. Elie C, Coste J,; French Society of Clinical Cytology Study Group. A methodological framework to distinguish spectrum effects from spectrum biases and to assess diagnostic and screening test accuracy for patient populations: application to the Papanicolaou cervical cancer smear test. BMC Med Res Methodol 2008; 8: 7.
23. Gimbergues P, Dauplat MM, Cayre A, Durando X, Le Bouedec G, Finat-Duclos F, Portefaix G, Kwiatkowski F, Dauplat J, Penault-Llorca F, Tchirkov A,. Correlation between molecular metastasis in sentinel lymph nodes of breast cancer patients and St. Gallen risk category. Eur J Surg Oncol 2007; 33: 16-22. (Pubitemid 46131872)
24. Roncella S, Ferro P, Bacigalupo B, Dessanti P, Giannico A, Gorji N, Moroni M, Tozzini S, Pensa F, Gianquinto D, Fais F, Pronzato P, et al. Relationship between human mammaglobin mRNA expression in breast cancer tissue and clinico-pathologic features of the tumors. J Exp Clin Cancer Res 2006; 25: 65-72.
25. Parikh RR, Yang Q, Higgins SA, Haffty BG,. Outcomes in young women with breast cancer of triple-negative phenotype: the prognostic significance of CK19 expression. Int J Radiat Oncol Biol Phys 2008; 70: 35-42. (Pubitemid 350251027)
26. Noguchi S, Aihara T, Motomura K, Inaji H, Imaoka S, Koyama H,. Histologic characteristics of breast cancers with occult lymph node metastasis detected by keratin 19 mRNA reverse transcriptase-polymerase chain reaction. Cancer 1996; 78: 1235-40. (Pubitemid 26303889)
27. Bostick PJ, Huynh KT, Sarantou T, Turner RR, Qi K, Giuliano AE, Hoon DS,. Detection of metastasis in sentinel lymph nodes of breast cancer patients by multiple-marker RT-PCR. Int J Cancer 1998; 79: 645-51. (Pubitemid 28549479)
28. Lockett MA, Baron PL, O'Brien PH, Elliott BM, Robison JG, Maitre N, Metcalf JS, Cole DJ,. Detection of occult breast cancer micrometastasis in axillary lymph nodes using a multimarker reverse transcriptase-polymerase chain reaction panel. J Am Coll Surg 1998; 187: 9-16. (Pubitemid 28303529)
29. Masuda N, Tamaki Y, Sakita I, Ooka M, Ohnishi T, Kadota M, Aritake N, Okubo K, Monden M,. Clinical significance of micrometastasis in axillary lymph nodes assessed by reverse transcription-polymerase chain reaction in breast cancer patients. Clin Cancer Res 2000; 6: 4176-85.
30. Zieglschmid V, Hollmann C, Böcher O,. Detection of disseminated tumor cells in peripheral blood. Crit Rev Clin Lab Sci 2005; 42: 155-96. (Pubitemid 41647727)
31. Maiorano E, Mazzarol GM, Pruneri G, Mastropasqua MG, Zurrida S, Orvieto E, Viale G,. Ectopic breast tissue as a possible cause of false-positive axillary sentinel lymph node biopsies. Am J Surg Pathol 2003; 27: 513-18. (Pubitemid 36368550)
32. Daniele L, Annaratone L, Allia E, Mariani S, Armando E, Bosco M, Macri L, Cassoni P, D'Armento G, Bussolati G, Cserni G, Sapino A,. Technical limits of comparison of step-sectionning, immunohistochemistry and RT-PCR on breast cancer sentinel nodes: a study on methacaran fixed tissue. J Cell Mol Med 2009; 13: 4042-50.
33. Manzotti M, Dell'Orto P, Maisonneuve P, Zurrida S, Mazzarol G, Viale G,. Reverse transcription-polymerase chain reaction assay for multiple mRNA markers in the detection of breast cancer metastasis in sentinel lymph nodes. Int J Cancer 2001; 95: 307-12. (Pubitemid 32847041)
34. de Mascarel I, MacGrogan G, Debled M, Brouste V, Mauriac L,. Distinction between isolated tumor cells and micrometastasis in breast cancer. Cancer 2008; 112: 1672-8. (Pubitemid 351551810)
35. Pugliese MS, Beatty JD, Tickman RJ, Allison KH, Atwood MK, Szymonifka J, Arthurs ZM, Huynh PP, Dawson JH,. Impact and outcomes of routine microstaging of sentinel lymph nodes in breast cancer: significance of the pN0(i+) and pN1mi categories. Ann Surg Oncol 2009; 16: 113-20.
36. Reed J, Rosman M, Verbanac KM, Mannie A, Cheng Z, Tafra L,. Prognostic implications of isolated tumor cells and micrometastasis in sentinel nodes of patients with invasive breast cancer: 10-year analysis of patients enrolled in the prospective East Carolina University/Anne Arundel Medical Center Sentinel Node Multicenter Study. J Am Coll Surg 2009; 208: 333-40.
37. de Boer M, van Deurzen CHM, van Dijck JAAM, Borm GF, van Diest PJ, Adang EM, Nortier JW, Rutgers EJ, Seynaeve C, Menke-Pluymers MB, Bult P, Tjan-Heijnen VC,. Micrometastasis or isolated tumor cells and the outcome of breast cancer. N Engl J Med 2009; 361: 653-63.